Nicholas Lewin's Insider Trades & SAST Disclosures
Nicholas Lewin's most recent trade in Establishment Labs Holdings Inc was a trade of 542 Common Shares done at an average price of $46.1 . Disclosure was reported to the exchange on Dec. 31, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Nicholas Lewin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Establishment Labs Holding... | Nicholas S. Lewin | Director | Grant, award, or other acquisition of securities at price $ 46.07 per share. | 31 Dec 2024 | 542 | 1,071,313 (4%) | 0% | 46.1 | 24,970 | Common Shares |
| Cutera Inc | Nicholas S. Lewin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 20,000 | 45,327 | - | - | Stock Option (Right to Buy) | |
| Establishment Labs Holding... | Nicholas S. Lewin | Director | Grant, award, or other acquisition of securities at price $ 43.27 per share. | 30 Sep 2024 | 577 | 1,070,771 (4%) | 0% | 43.3 | 24,967 | Common Shares |
| Cutera Inc | Nicholas S. Lewin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 25,327 | 25,327 | - | - | Stock Option (Right to Buy) | |
| Cutera Inc | Nicholas S. Lewin | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2024 | 25,327 | 0 | - | - | Stock Option (Right to Buy) | |
| Establishment Labs Holding... | Nicholas S. Lewin | Director | Grant, award, or other acquisition of securities at price $ 45.44 per share. | 30 Jun 2024 | 550 | 1,070,194 (4%) | 0% | 45.4 | 24,992 | Common Shares |
| Establishment Labs Holding... | Nicholas S. Lewin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 2,334 | 1,069,644 (4%) | 0% | 0 | Common Shares | |
| Establishment Labs Holding... | Nicholas Lewin | Director | Grant, award, or other acquisition of securities at price $ 50.90 per share. | 31 Mar 2024 | 491 | 1,067,310 (4%) | 0% | 50.9 | 24,992 | Common Shares |
| Establishment Labs Holding... | Lewin Nicholas | Director | Grant, award, or other acquisition of securities at price $ 25.89 per share. | 31 Dec 2023 | 1,931 | 1,066,819 (4%) | 0% | 25.9 | 49,994 | Common Shares |
| Establishment Labs Holding... | Nicholas Lewin | Director | Purchase of securities on an exchange or from another person at price $ 27.05 per share. | 14 Dec 2023 | 1,769 | 1,064,888 (4%) | 0% | 27.0 | 47,846 | Common Shares |
| Establishment Labs Holding... | Lewin Nicholas | Director | Purchase of securities on an exchange or from another person at price $ 26.96 per share. | 14 Dec 2023 | 231 | 1,063,119 (4%) | 0% | 27.0 | 6,227 | Common Shares |
| Establishment Labs Holding... | Nicholas Lewin | Director | Purchase of securities on an exchange or from another person at price $ 56.13 per share. | 15 Aug 2023 | 400 | 9,190 (0%) | 0% | 56.1 | 22,452 | Common Shares |
| Establishment Labs Holding... | Nicholas Lewin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2023 | 27,756 | 812,888 (3%) | 0% | 0 | Common Shares | |
| Establishment Labs Holding... | Nicholas Lewin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 2,324 | 785,132 (3%) | 0% | 0 | Common Shares | |
| Cutera Inc | Nicholas Lewin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 25,327 | 25,327 | - | - | Stock Option (Right to Buy) | |
| Establishment Labs Holding... | Nicholas Lewin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 7,829 | 7,829 | - | - | Stock Option (Right to buy) | |
| Establishment Labs Holding... | Nicholas Lewin | Director | Other type of transaction at price $ 0.00 per share. | 10 Sep 2022 | 36,780 | 0 | - | - | Stock Option (Right to buy) | |
| Establishment Labs Holding... | Nicholas Lewin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 2,345 | 782,808 (3%) | 0% | 0 | Common Shares | |
| Establishment Labs Holding... | Nicholas Lewin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to buy) | |
| Establishment Labs Holding... | Nicholas Lewin | Director | Purchase of securities on an exchange or from another person at price $ 59.97 per share. | 17 Mar 2021 | 350 | 350 (0%) | 0% | 60.0 | 20,990 | Common Shares |
| Establishment Labs Holding... | Nicholas Lewin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to buy) | |
| Establishment Labs Holding... | Nicholas Lewin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2020 | 10,000 | 10,000 | - | - | Stock Option (Right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges